Wednesday, February 10, 2010, 8:45AM AEST - The Australian Stockmarket opens in 1 hour and 15 minutes.
To create a watchlist or portfolio of shares, Register

Parexel International Corp. (PRXL)

8:00AM AEST: 19.25 USD  Down 0.48 (2.43%)  
 MORE ON PRXL 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 PAREXEL International Corporati (NasdaqNM:PRXL) Delayed quote dataEdit
Last Trade:19.25 USD
Trade Time: 8:00AM AEST
Change:Down 0.48 (2.43%)
Prev Close:19.73
Open:19.91
Bid:18.81 x 700
Ask:19.27 x 400
1y Target Est:17.00
Day's Range:19.16 - 19.96
52wk Range:7.20 - 21.10
Volume:747,211
Avg Vol (3m):547,487
Market Cap:1.12B
P/E (ttm):29.21
EPS (ttm):0.66
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add PRXL to Portfolio   Download Data

 HEADLINES 
PAREXEL INTERNATIONAL CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Sat, Feb 6)
Biologic And Diagnostic Device Research And Development Expenditures Drive Stock Winners With Or Without Congressional Legislation According To Northland Securities
Wall Street Transcript (Thu, Jan 28)
Leading Lymphoma Expert Joins Perceptive Informatics Team of Medical Imaging Scientific Advisors
PR Newswire (Wed, Jan 27)
PAREXEL International Corporation F2Q10 (Qtr End 12/31/09) Earnings Call Transcript
at Seeking Alpha (Wed, Jan 27)
Parexel hits annual high on 2Q results and demand
AP (Wed, Jan 27)
Parexel ups guidance after strong Q2
at bizjournals.com (Wed, Jan 27)
PAREXEL Earnings Call scheduled for 10:00 am ET today
CCBN (Wed, Jan 27)
Early-Market Movers: VMware, Weatherford International
at Fox Business (Wed, Jan 27)
New Star Analyst Rankings for PAREXEL International Corporati
StarMine (Wed, Jan 27)
PAREXEL INTERNATIONAL CORP Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Tue, Jan 26)
More Headlines for PRXL...

 ANALYST 
EPS Est (next year) (Jun-10) :0.94
EPS Est (in 2 years) (Jun-11) :1.17
Avg Rec (current)*:2.0
PEG Ratio:1.38
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
PAREXEL International Corporation, a biopharmaceutical services company, provides clinical research, medical communications services, consulting and informatics, and technology products and services to the pharmaceutical, biotechnology, and medica...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices